Search

everythinglearnresearchcommunity

for

Search:↓

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

PCOS may be influenced by factors in the blood, not just the ovaries.

Autoimmune markers may help diagnose and manage PCOS.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Reference values for nine hormones were established to help diagnose PCOS.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

The new rodent model successfully mimics non-lean human PCOS symptoms.

New methods may speed up drug development for male subfertility.

PCOS may have evolved as an advantage in past environments with food scarcity.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The ketogenic diet may help manage PCOS symptoms but needs more research for long-term effects.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.